Alto Neuroscience, Inc. (ANRO)
24.91
-0.75
(-2.92%)
USD |
NYSE |
May 01, 16:00
24.91
0.00 (0.00%)
After-Hours: 20:00
Alto Neuroscience Shareholders Equity (Quarterly) : 151.14M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| Immunovant, Inc. | 986.14M |
| Halozyme Therapeutics, Inc. | 48.81M |
| Vertex Pharmaceuticals, Inc. | 18.67B |
| Fortress Biotech, Inc. | 49.87M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 184.69M |
| Total Liabilities (Quarterly) | 33.55M |
| Debt to Equity Ratio | 0.1585 |
| Current Ratio | 15.69 |
| Net Debt Paydown Yield | -0.25% |